The Economic Burden of Alcohol Dependence in Europe, Alcohol and Alcoholism, vol.48, issue.3, pp.259-69, 2013. ,
DOI : 10.1093/alcalc/agt004
Guideline on the development of medicinal products for the treatment of alcohol dependence, 2010. ,
Harm reduction approaches to alcohol use, Addictive Behaviors, vol.27, issue.6, pp.867-86, 2002. ,
DOI : 10.1016/S0306-4603(02)00294-0
The treatment gap in mental health care, Bull World Health Organ, vol.82, issue.11, pp.858-66, 2004. ,
Emerging pharmacotherapies for alcohol dependence: A systematic review focusing on reduction in consumption, Drug and Alcohol Dependence, vol.133, issue.1, pp.15-29, 2013. ,
DOI : 10.1016/j.drugalcdep.2013.04.025
Société Française d'Alcoologie Conférence de consensus 7 et 8 mars 2001: modalités de l'accompagnement du sujet alcoolodépendant après un sevrage ,
Société Française d'Alcoologie Conférence de consensus du 17 mars 1999: Objectifs, indications et modalités du sevrage du patient alcoolodépendant ,
Abstinence dans l???alcoolod??pendance??: approche critique et actualis??e des recommandations nationales de 2001, La Presse M??dicale, vol.42, issue.1, pp.19-25, 2001. ,
DOI : 10.1016/j.lpm.2012.02.038
The System of Medical Treatment for Addiction in France, International Journal of Mental Health, vol.6, issue.3, pp.19-26, 2014. ,
DOI : 10.1192/bjp.bp.108.054742
ALCOHOL-DEPENDENCE: THE CURRENT FRENCH CRAZE FOR BACLOFEN, Addiction, vol.65, issue.4, pp.848-857, 2012. ,
DOI : 10.1111/j.1360-0443.2011.03752.x
Alcohol misuse: screening, diagnosis and treatment, 2015. ,
Mésusage de l'alcool: dépistage, diagnostic et traitement Recommandations de bonne pratique, Alcoologie et Addictologie, vol.37, issue.1, 2015. ,
The New French Guidelines on Alcohol Misuse: An Initiative for Strengthening Cross-European Interplay, Addiction, vol.20, issue.8, pp.1362-1365, 2015. ,
DOI : 10.1111/add.12997
Practice Guidelines Clinical practice guidelines " method, 2011. ,
About HAS ,
Reduction in heavy drinking as a treatment outcome in alcohol dependence, Journal of Substance Abuse Treatment, vol.33, issue.1, pp.71-80, 2007. ,
DOI : 10.1016/j.jsat.2006.09.008
Patient preferences and perspectives regarding reducing alcohol consumption: role of nalmefene, Patient Prefer Adherence, vol.8, pp.1347-52, 2014. ,
A 60-year follow-up of alcoholic men, Addiction, vol.6, issue.8, pp.1043-51, 2003. ,
DOI : 10.1046/j.1360-0443.2003.00422.x
Treatment for Alcohol Dependence in Catalonia: Health Outcomes and Stability of Drinking Patterns over 20 Years in 850 Patients, Alcohol and Alcoholism, vol.44, issue.4, pp.409-424, 2009. ,
DOI : 10.1093/alcalc/agp032
Differences between abstinent and non-abstinent individuals in recovery from alcohol use disorders, Addictive Behaviors, vol.39, issue.12, pp.1730-1735, 2014. ,
DOI : 10.1016/j.addbeh.2014.07.010
Accounting for self-selected drinking goals in the assessment of treatment outcome., Psychology of Addictive Behaviors, vol.22, issue.3, pp.439-482, 2008. ,
DOI : 10.1037/0893-164X.22.3.439
Initial Preference for Drinking Goal in the Treatment of Alcohol Problems: II. Treatment Outcomes, Alcohol and Alcoholism, vol.45, issue.2, pp.136-178, 2010. ,
DOI : 10.1093/alcalc/agq005
The alcohol withdrawal syndrome, The Lancet, vol.349, issue.9069, pp.1897-900, 1997. ,
DOI : 10.1016/S0140-6736(97)04572-8
The ???Prediction of Alcohol Withdrawal Severity Scale??? (PAWSS): Systematic literature review and pilot study of a new scale for the prediction of complicated alcohol withdrawal syndrome, Alcohol, vol.48, issue.4, pp.375-90, 2014. ,
DOI : 10.1016/j.alcohol.2014.01.004
Alcohol-use disorders, The Lancet, vol.373, issue.9662, pp.492-501, 2009. ,
DOI : 10.1016/S0140-6736(09)60009-X
Comparative Effectiveness and Costs of Inpatient and Outpatient Detoxification of Patients with Mild-to-Moderate Alcohol Withdrawal Syndrome, New England Journal of Medicine, vol.320, issue.6, pp.358-65, 1989. ,
DOI : 10.1056/NEJM198902093200605
Benzodiazepines for alcohol withdrawal, Cochrane Database Syst Rev, vol.152, issue.3, p.5063, 2010. ,
DOI : 10.1002/14651858.CD005063.pub3
People with Alcohol Use Disorders in Specialized Care in Eight Different European Countries, Alcohol and Alcoholism, vol.50, issue.3, pp.310-318, 2015. ,
DOI : 10.1093/alcalc/agv009
Symptom-Triggered vs Fixed-Schedule Doses of Benzodiazepine for Alcohol Withdrawal, Archives of Internal Medicine, vol.162, issue.10, pp.1117-1138, 2002. ,
DOI : 10.1001/archinte.162.10.1117
Assessment of Alcohol Withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar), Addiction, vol.26, issue.11, pp.1353-1360, 1989. ,
DOI : 10.1111/j.1360-0443.1989.tb00737.x
Alcohol Withdrawal Syndromes: Clinical Management with Lofexidine, Alcoholism: Clinical and Experimental Research, vol.282, issue.2, pp.103-111, 1985. ,
DOI : 10.1001/jama.239.14.1409
Glucuronidation of oxazepam is not spared in patients with hepatic encephalopathy, Hepatology, vol.29, issue.6, pp.951-957, 1990. ,
DOI : 10.1002/hep.1840110607
Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders):911?5. 35. US Department of Helath & Human Services, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism. Helping patients who drink too much. A clinican's guide, Intern Med J, vol.4415, issue.9, p.9, 2005. ,
Lack of international consensus in low-risk drinking guidelines, Drug and Alcohol Review, vol.28, issue.1, pp.11-19, 2013. ,
DOI : 10.1111/j.1465-3362.2012.00475.x
Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review, Addiction, vol.99, issue.7, pp.811-839, 2004. ,
Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?, Addiction, vol.154, issue.12, pp.275-93, 2013. ,
DOI : 10.1111/j.1360-0443.2012.04054.x
Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings, JAMA, vol.311, issue.18, pp.1889-900, 2014. ,
DOI : 10.1001/jama.2014.3628
The Efficacy of Disulfiram for the Treatment of Alcohol Use Disorder, Alcoholism: Clinical and Experimental Research, vol.64, issue.2, pp.1749-58, 2011. ,
DOI : 10.1111/j.1530-0277.2011.01523.x
Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis, PLoS ONE, vol.74, issue.2, p.87366, 2014. ,
DOI : 10.1371/journal.pone.0087366.s002
Safety Issues Concerning the Use of Disulfiram in Treating Alcohol Dependence, Drug Safety, vol.20, issue.5, pp.427-462, 1999. ,
DOI : 10.2165/00002018-199920050-00003
Baclofen for alcohol dependence in France: Incidence of treated patients and prescription patterns???A cohort study, European Neuropsychopharmacology, vol.24, issue.2, pp.192-201, 2014. ,
DOI : 10.1016/j.euroneuro.2013.09.008
Off-Label Baclofen Prescribing Practices among French Alcohol Specialists: Results of a National Online Survey, PLoS ONE, vol.7, issue.302, p.98062, 2014. ,
DOI : 10.1371/journal.pone.0098062.t003
High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial Baclofen for the Treatment of Alcohol Drinkers -Full Text View -ClinicalTrials.gov, Eur Neuropsychopharmacol BACLOVILLE study, vol.2515, issue.46, pp.1167-77, 2012. ,
Efficacy and Safety of Baclofen for Maintenance of Abstinence in Alcohol Dependent Patients -Full Text View -ClinicalTrials.gov. http://clinicaltrials.gov/show, p.1738282 ,
Severe Tinnitus Induced by Off-Label Baclofen, Annals of Pharmacotherapy, vol.104, issue.5, pp.656-665, 2014. ,
DOI : 10.3389/fneur.2012.00034
Tolerability of High-dose Baclofen in the Treatment of Patients with Alcohol Disorders: A Retrospective Study, Alcohol and Alcoholism, vol.50, issue.5, pp.551-558, 2015. ,
DOI : 10.1093/alcalc/agv052
Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation, European Neuropsychopharmacology, vol.25, issue.10, 2015. ,
DOI : 10.1016/j.euroneuro.2015.05.008
A Case of De novo Seizures Following a Probable Interaction of High-Dose Baclofen with Alcohol, Alcohol and Alcoholism, vol.47, issue.5, pp.577-80, 2012. ,
DOI : 10.1093/alcalc/ags076
Baclofen-Induced Manic Symptoms: Case Report and Systematic Review, Psychosomatics, vol.55, issue.4, pp.326-358, 2014. ,
DOI : 10.1016/j.psym.2014.02.003
Assessing Alcohol Versus Baclofen Withdrawal Syndrome in Patients Treated With Baclofen for Alcohol Use Disorder, Journal of Clinical Psychopharmacology, vol.34, issue.1, pp.153-159, 2014. ,
DOI : 10.1097/JCP.0000000000000054
Recommandation temporaire d'utilisation (RTU) pour le baclofène -Point d'information 2014. http://ansm.sante.fr/Sinformer/Actualite/Une-recommandation-temporaire-d-utilisation-RTU-est-accordee-pour-lebaclofene-Point-d-information ,
Average Volume of Alcohol Consumption, Patterns of Drinking, and All-Cause Mortality: Results from the US National Alcohol Survey, American Journal of Epidemiology, vol.153, issue.1, pp.64-71, 2001. ,
DOI : 10.1093/aje/153.1.64
Reduction of Drinking in Problem Drinkers and All-Cause Mortality, Alcohol and Alcoholism, vol.48, issue.4, pp.509-522, 2013. ,
DOI : 10.1093/alcalc/agt021
Identification of behaviour change techniques to reduce excessive alcohol consumption, Addiction, vol.103, issue.2, pp.1431-1471, 2012. ,
DOI : 10.1111/j.1360-0443.2012.03845.x
Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene, Biological Psychiatry, vol.73, issue.8, pp.706-719, 2013. ,
DOI : 10.1016/j.biopsych.2012.10.020
Acamprosate supports abstinence, Naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes, Journal of Psychopharmacology, vol.22, issue.1, pp.11-23, 2008. ,
DOI : 10.1177/0269881107078308
The effects of benzodiazepine use during pregnancy and lactation, Reproductive Toxicology, vol.8, issue.6, pp.461-75, 1994. ,
DOI : 10.1016/0890-6238(94)90029-9
Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations, Pharmacoepidemiology and Drug Safety, vol.9, issue.11, pp.1203-1213, 2007. ,
DOI : 10.1002/pds.1457
Relationship of Age of First Drink to Child Behavioral Problems and Family Psychopathology, Alcoholism: Clinical & Experimental Research, vol.1, issue.10, pp.1869-76, 2005. ,
DOI : 10.1016/S0741-8329(99)00020-8
Adolescent alcohol use is a risk factor for adult alcohol and drug dependence: evidence from a twin design, Psychological Medicine, vol.36, issue.01, pp.109-127, 2006. ,
DOI : 10.1017/S0033291705006045
Long v short half-life benzodiazepines in the elderly???kinetics and clinical effects of diazepam and oxazepam, Journal of Clinical Psychopharmacology, vol.3, issue.4, pp.293-300, 1983. ,
DOI : 10.1097/00004714-198308000-00016
The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam and lorazepam in man, Acta Psychiatrica Scandinavica, vol.25, issue.This suppl., pp.56-74, 1978. ,
DOI : 10.1111/j.1600-0447.1978.tb02388.x
Use of benzodiazepines and association with falls in older people admitted to hospital: a prospective cohort study The epidemiology of at-risk and binge drinking among middle-aged and elderly community adults: National Survey on Drug Use and Health, 299?310. 67. Blazer DG, pp.1162-1171, 2009. ,
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study, The Lancet, vol.370, issue.9603, pp.1915-1937, 2007. ,
DOI : 10.1016/S0140-6736(07)61814-5
Trajectories of Alcohol Consumption Following Liver Transplantation, American Journal of Transplantation, vol.6, issue.10, pp.2305-2317, 2010. ,
DOI : 10.1111/j.1600-6143.2010.03232.x
Liver transplantation in patients with alcoholic liver disease, Liver Transplantation, vol.42, issue.suppl), pp.751-760, 2011. ,
DOI : 10.1002/lt.22330
Recurrent Alcoholic Cirrhosis In Severe Alcoholic Relapse After Liver Transplantation: A Frequent and Serious Complication, The American Journal of Gastroenterology, vol.105, issue.8, pp.1160-1166, 2015. ,
DOI : 10.1038/ajg.2015.204
Longitudinal changes in cognition, gait, and balance in abstinent and relapsed alcoholic men: Relationships to changes in brain structure., Neuropsychology, vol.14, issue.2, pp.178-88, 2000. ,
DOI : 10.1037/0894-4105.14.2.178
Diagnosis of depression in alcohol dependence: changes in prevalence with drinking status, The British Journal of Psychiatry, vol.166, issue.2, pp.199-204, 1995. ,
DOI : 10.1192/bjp.166.2.199
Impact of alcohol detoxification on anxiety and depressive symptoms, Drug and Alcohol Dependence, vol.68, issue.2, pp.215-235, 2002. ,
DOI : 10.1016/S0376-8716(02)00195-3
Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment):681?91. 77. National Institute for Health and Clinical Excellence. Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence, ):1?22. 76. Joseph AM, p.9, 2004. ,
Department of Health and Ageing. Guidelines for the Treatment of Alcohol Problems, 2009. ,
Benzodiazepines for alcohol withdrawal in the elderly and in patients with liver disease, Pharmacotherapy, vol.16, pp.49-57, 1996. ,
Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal, JAMA: The Journal of the American Medical Association, vol.278, issue.2, pp.144-151, 1997. ,
DOI : 10.1001/jama.278.2.144
Clinical Pharmacokinetics of Oxazepam and Lorazepam, Clinical Pharmacokinetics, vol.6, issue.2, pp.89-105, 1981. ,
DOI : 10.2165/00003088-198106020-00001
Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses, Cochrane Database Syst Rev, vol.10, issue.1, p.6266, 2010. ,
DOI : 10.1002/14651858.CD006266.pub2
COMPLETE AND PROLONGED SUPPRESSION OF SYMPTOMS AND CONSEQUENCES OF ALCOHOL-DEPENDENCE USING HIGH-DOSE BACLOFEN: A SELF-CASE REPORT OF A PHYSICIAN, Alcohol and Alcoholism, vol.40, issue.2, pp.147-50, 2005. ,
DOI : 10.1093/alcalc/agh130
Baclofen: the new miracle cure for alcoholism?] Le baclofène sera-t-il le nouveau médicament miracle de l'alcoolisme?, Rev Med Suisse, vol.7, issue.302, pp.1458-61, 2011. ,
Why Belgian alcohol patients are treated differently than their French counterparts High-dose baclofen for treatment-resistant alcohol dependence GABAB agonists for the treatment of Alcohol Use Disorder, 315?6. 86. Pastor A, pp.3367-72, 2012. ,
Initial Preference for Drinking Goal in the Treatment of Alcohol Problems: I. Baseline Differences Between Abstinence and Non-Abstinence Groups, Alcohol and Alcoholism, vol.45, issue.2, pp.128-163, 2010. ,
DOI : 10.1093/alcalc/agp096
ESENSE 2 Study Group. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies, Eur Neuropsychopharmacol Alcohol Alcohol, vol.23, issue.485, pp.570-578, 2013. ,
Clinical Relevance of As-Needed Treatment with Nalmefene in Alcohol-Dependent Patients, European Addiction Research, vol.21, issue.3, pp.160-168, 2015. ,
DOI : 10.1159/000371547
The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients, PLOS ONE, vol.10, issue.15, p.129289, 2015. ,
DOI : 10.1371/journal.pone.0129289.t004
Why should we need a European Federation of Addiction Societies?, Addiction, vol.88, issue.4, pp.6-8, 2008. ,
DOI : 10.1111/j.1360-0443.2011.03666.x